Pay in 4 interest-free payments of $6.36 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Semaglutide is ideal for individuals struggling with weight loss who have a BMI of 25 or higher with weight-related conditions or a BMI of 30 or more
Research in PMC shows that NNMT inhibition: Normalizes glucose tolerance Reduces fasting blood glucose levels Increases production of PAHSAs (anti-diabetic lipids) Improves insulin signaling in fat and muscle tissue This makes 5-amino-1MQ particularly interesting for people with prediabetes or metabolic syndrome
Research applications In-vitro modeling of synergistic GHRH/GHRP receptor cross-talk Pre-clinical study of pulsatile GH-secretagogue dynamics Comparative receptor-pathway research (cAMP vs calcium convergence) Reference standard for analytical characterization of blended preparations Key facts Combines a GHRH-receptor analog with a selective GHS-R1a agonist Nominal 5mg + 5mg per-component loading per vial Components act through mechanistically independent, convergent pathways Supplied as a co-lyophilized research powder for in-vitro use Product specifications Class: GHRH analog + GHRP/ghrelin-receptor agonist research blend Also known as: Mod-GRF + Ipamorelin blend Form: Lyophilized powder vial Purity: 99% (HPLC verified) Testing: Independent third-party HPLC + mass spectrometry Documentation: Certificate of analysis per batch Storage: Store lyophilized at -20C
the Injection
J., Craik, D
When paired with a balanced diet and regular exercise, sustainable results appear when applied with the addition of semaglutide near Macomb, MI
US$ 27.85
US$ 22.10
US$ 22.17
US$ 20.10
US$ 28.26
